BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2015 5:05:00 PM | Browse: 1387 | Download: 3344
 |
Received |
|
2015-01-29 21:15 |
|
Peer-Review Started |
|
2015-01-30 21:30 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2015-03-16 09:00 |
|
Revised |
|
2015-04-16 01:25 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-05-29 14:05 |
|
Second Decision by Editor-in-Chief |
|
2015-05-29 19:32 |
|
Final Decision by Editorial Office Director |
|
2015-06-10 16:08 |
|
Articles in Press |
|
2015-06-10 16:08 |
|
Edit the Manuscript by Language Editor |
|
2015-07-21 21:12 |
|
Typeset the Manuscript |
|
2015-08-13 17:48 |
|
Publish the Manuscript Online |
|
2015-08-28 17:04 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jia-Li Wang, Xin-Fang Du, Shao-Long Chen, Yi-Qi Yu, Jing Wang, Xi-Qi Hu, Ling-Yun Shao, Jia-Zhen Chen, Xin-Hua Weng and Wen-Hong Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Key Medical Specialties Fund of Shanghai Municipal Health Bureau |
05II011 2-1 |
|
| Corresponding Author |
Wen-Hong Zhang, Professor, Department of Infectious Diseases, Huashan Hospital, 12 Wulumuqi Zhong Road, Shanghai 200040, China. zhangwenhong@fudan.edu.cn |
| Key Words |
Advanced fibrosis; Chronic hepatitis B; Cirrhosis; Entecavir; Histological outcome; Lamivudine |
| Core Tip |
This retrospective cohort study compared the histological outcomes of long-term antiviral treatment for an average of more than 3 years with entecavir monotherapy or lamivudine-based combination therapy in chronic hepatitis B patients with significant fibrosis or cirrhosis. There was a histological improvement observed in the majority of patients in both arms. There were also improved virological responses, alanine aminotransferase normalization, and serological responses. Additionally, 4 of 48 patients achieved a full reversion of fibrosis or cirrhosis. Entecavir was superior to lamivudine-based therapy in improving necroinflammatory but not fibrotic outcome. |
| Publish Date |
2015-08-28 17:04 |
| Citation |
Wang JL, Du XF, Chen SL, Yu YQ, Wang J, Hu XQ, Shao LY, Chen JZ, Weng XH, Zhang WH. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy. World J Gastroenterol 2015; 21(32): 9598-9606 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i32/9598.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i32.9598 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
